Autoantibody profiling for predictive biomarkers for immune-related adverse events and clinical benefit in rare tumors treated with anti-PD-1 therapy

被引：0
|
作者：
Derbala, Mohamed H.
Hajjar, Joud
Stephen, Bettzy
Gurses, Serdar A.
Kwiatkowski, Evan
Budde, Petra
Zucht, Hans-Dieter
Brautigam, Manuel
Schubert, Ann-Sophie
Ahangarianabhari, Behnaz
Rodriguez, Enedelia
Gouda, Mohamed
Castillo, Lilibeth
Zarifa, Abdulrazzak
How, Jeffrey A.
Moyers, Justin T.
Hong, David S.
Meric-Bernstam, Funda
Naing, Aung
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5141
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5141
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis
    Wang, Peng-Fei
    Chen, Yang
    Song, Si-Ying
    Wang, Ting-Jian
    Ji, Wen-Jun
    Li, Shou-Wei
    Liu, Ning
    Yan, Chang-Xiang
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [42] Antinuclear antibody (ANA) status predicts immune-related adverse events in liver cancer patients undergoing anti-PD-1 therapy
    Hsu, Shu-Jung
    Chao, Yen-Cheng
    Lin, Xia-Hui
    Liu, Hua-Hua
    Zhang, Yang
    Hong, Wei-Feng
    Chen, Mao-Pei
    Xu, Xin
    Zhang, Lan
    Ren, Zheng-Gang
    Du, Shi-Suo
    Chen, Rong-Xin
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2023, 212 (03): : 239 - 248
  • [43] Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy
    Shafqat, Hammad
    Gourdin, Theodore
    Sion, Amy
    SEMINARS IN ONCOLOGY, 2018, 45 (03) : 156 - 163
  • [44] Immune-Related Adverse Events Associated With Outcomes in Patients With NSCLC Treated With Anti-PD-1 Inhibitors: A Systematic Review and Meta-Analysis
    Zhao, Zhe
    Wang, Xinfeng
    Qu, Jinghan
    Zuo, Wei
    Tang, Yan
    Zhu, Huijuan
    Chen, Xiaoguang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] Usefulness of the nCounter Analysis System to Monitor Immune-related Biomarkers in PBMCs During Anti-PD-1 Therapy
    Morisaki, Takafumi
    Kubo, Makoto
    Umebayashi, Masayo
    Yuan, Yuan
    Tsuyada, Akihiro
    Tanaka, Hiroto
    Koya, Norihiro
    Nakagawa, Shinichirou
    Morisaki, Takashi
    Nakamura, Masafumi
    ANTICANCER RESEARCH, 2019, 39 (08) : 4517 - 4523
  • [46] Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation
    Vinnakota, Janaki Manoja
    Adams, Rachael C.
    Athanassopoulos, Dimitrios
    Schmidt, Dominik
    Biavasco, Francesca
    Zaehringer, Alexander
    Erny, Daniel
    Schwabenland, Marius
    Langenbach, Marlene
    Wenger, Valentin
    Salie, Henrike
    Cook, James
    Mossad, Omar
    Andrieux, Geoffroy
    Dersch, Rick
    Rauer, Sebastian
    Duquesne, Sandra
    Monaco, Gianni
    Wolf, Phillipp
    Blank, Thomas
    Haene, Philipp
    Greter, Melanie
    Becher, Burkhard
    Henneke, Philipp
    Pfeifer, Dietmar
    Blazar, Bruce R.
    Duyster, Justus
    Boerries, Melanie
    Koehler, Natalie
    Chhatbar, Chintan M.
    Bengsch, Bertram
    Prinz, Marco
    Zeiser, Robert
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (751)
  • [47] Association between immune-related adverse events and efficacy in patients treated with anti-PD-(L)1
    Kfoury, M.
    Voisin, A-L.
    Najean, M.
    Champiat, S.
    Laghouati, S.
    Michot, J-M.
    Robert, C.
    Mateus, C.
    Albiges, L.
    Besse, B.
    Massard, C.
    Texier, M.
    Lambotte, O.
    Marabelle, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [48] Serum multiplex analysis of checkpoint proteins in association with immune-related adverse events in patients with melanoma receiving adjuvant anti-PD-1 therapy
    Knight, Andrew David
    Bruno, Sabrina
    Layding, Caroline Jane
    Wang, Hong
    Sander, Cindy
    Storkus, Walter J.
    Karapetyan, Lilit
    Kirkwood, John M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma
    Shibata, Yosuke
    Kishida, Takeshi
    Kouro, Taku
    Wei, Feifei
    Igarashi, Yuka
    Himuro, Hidetomo
    Noguchi, Takeaki
    Koizumi, Mitsuyuki
    Suzuki, Takahisa
    Osaka, Kimito
    Saigusa, Yusuke
    Sasada, Tetsuro
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [50] Diet-induced obesity predisposes anti-PD-1 antibody-treated mice to imiquimod-mediated psoriasiform dermatitis: implications for immune-related adverse events in cancer patients treated with anti-PD-1
    Yu, S.
    Wu, X.
    Shi, Z.
    Huynh, M.
    Hwang, S. T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S4 - S4
12345